Matching Inflammation and Immunology Models to Mechanism and Endpoint October 10, 2026 No Comments Read More »
How to Evaluate an Immunological Disease Model Platform Before Outsourcing October 10, 2026 No Comments Read More »
How Autoimmune Drug Developers Can Choose More Informative Disease Models October 10, 2026 No Comments Read More »
What in Situ Tumor Models Can—and Cannot—Tell Researchers About Patient-Relevant Biology October 9, 2026 No Comments Read More »
Why Orthotopic Pancreatic Models Better Recreate Organ-Specific Tumor Biology October 9, 2026 No Comments Read More »
